Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A David Smith

Showing results (41-50 of 153) with videos related to

Pageof 16
Sort By:
The American Journal of Clinical Nutrition|February 4, 2015
Homocysteine lowering, B vitamins, and cognitive agingA David Smith, Celeste A de Jager, Helga Refsum, et al.
Neurology|October 2, 2009
Predicting the time of conversion to MCI in the elderly: role of verbal expression and learningAbderrahim Oulhaj, Gordon K Wilcock, A David Smith, et al.
Oxford Medical Case Reports|January 9, 2018
Elevated homocysteine and <i>N</i>-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndromeSimon Vann Jones, Subimal Banerjee, A David Smith, et al.
Archives of Neurology|May 22, 2002
Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer diseaseEva Hogervorst, Helen Mendes Ribeiro, Andrew Molyneux, et al.
BMC Psychology|January 8, 2015
The impact of early life factors on cognitive function in old age: The Hordaland Health Study (HUSK)Jens Christoffer Skogen, Simon Øverland, A David Smith, et al.
The Lancet. Global Health|September 16, 2022
Mandatory food fortification with folic acidA David Smith, Agata Sobczyńska-Malefora, Ralph Green, et al.
International Journal of Geriatric Psychiatry|July 23, 2011
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trialCeleste A de Jager, Abderrahim Oulhaj, Robin Jacoby, et al.
Neurobiology of Aging|April 12, 2008
PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patientsOlivia Belbin, Helen Beaumont, Donald Warden, et al.
Neurology|June 9, 2004
Low thyroid-stimulating hormone as an independent risk factor for Alzheimer diseaseLiesbeth A D M van Osch, Eva Hogervorst, Marc Combrinck, et al.
Gene|March 14, 2002
Human homologue of a gene mutated in the slow Wallerian degeneration (C57BL/Wld(s)) mouseF Shama Fernando, Laura Conforti, Sabrina Tosi, et al.
Pageof 16

Showing results (41-50 of 153) with videos related to

Sort By:
Pageof 16
The American Journal of Clinical Nutrition|February 4, 2015
Homocysteine lowering, B vitamins, and cognitive agingA David Smith, Celeste A de Jager, Helga Refsum, et al.
Neurology|October 2, 2009
Predicting the time of conversion to MCI in the elderly: role of verbal expression and learningAbderrahim Oulhaj, Gordon K Wilcock, A David Smith, et al.
Oxford Medical Case Reports|January 9, 2018
Elevated homocysteine and <i>N</i>-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndromeSimon Vann Jones, Subimal Banerjee, A David Smith, et al.
Archives of Neurology|May 22, 2002
Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer diseaseEva Hogervorst, Helen Mendes Ribeiro, Andrew Molyneux, et al.
BMC Psychology|January 8, 2015
The impact of early life factors on cognitive function in old age: The Hordaland Health Study (HUSK)Jens Christoffer Skogen, Simon Øverland, A David Smith, et al.
The Lancet. Global Health|September 16, 2022
Mandatory food fortification with folic acidA David Smith, Agata Sobczyńska-Malefora, Ralph Green, et al.
International Journal of Geriatric Psychiatry|July 23, 2011
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trialCeleste A de Jager, Abderrahim Oulhaj, Robin Jacoby, et al.
Neurobiology of Aging|April 12, 2008
PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patientsOlivia Belbin, Helen Beaumont, Donald Warden, et al.
Neurology|June 9, 2004
Low thyroid-stimulating hormone as an independent risk factor for Alzheimer diseaseLiesbeth A D M van Osch, Eva Hogervorst, Marc Combrinck, et al.
Gene|March 14, 2002
Human homologue of a gene mutated in the slow Wallerian degeneration (C57BL/Wld(s)) mouseF Shama Fernando, Laura Conforti, Sabrina Tosi, et al.
Pageof 16